Giovanni Battista Migliori, Dennis Falzon, Guy B. Marks, Delia Goletti, Tereza Kasaeva, Susanna Esposito, Marc Humbert
European Respiratory Journal 2022 59: 2200149; DOI: 10.1183/13993003.00149-2022
Tuberculosis (TB) remains a major public health concern worldwide. In 2020, it was the 13th leading cause of death and the second leading infectious killer after coronavirus disease 2019 (COVID-19), above HIV/AIDS. In 2020 a total of 1.5 million people died from TB, while about 10 million people are estimated to have suffered from the disease: 5.6 million men, 3.3 million women and 1.1 million children [1].
The ERJ commemorates World TB Day 2022 by publishing relevant articles to contribute to the fight against tuberculosis https://bit.ly/3gNby7P
Conflict of interest: D. Goletti reports grants from Biomerieux and Quidel; consulting fees from Biomerieux, Quidel, Qiagen and PDB Biotec; lecture honoraria from Biomerieux, Quidel, Amgen, Biogen, Celgene, Janssen and Diasorin; and participation on advisory boards for Biomerieux, PDB Biotec and Lilly; outside the submitted work. All other authors have nothing to disclose.